LEADER 01602nam  2200337z- 450 
001 9910694101103321
005 20060622171032.0
035   $a(CKB)5860000000018456
035   $a(BIP)013636445
035   $a(EXLCZ)995860000000018456
100   $a20220406c2005uuuu  -u-         -
101 0 $aeng
200 10$aBiodefense $enext steps : hearing before the Subcommittee on Bioterrorism and Public Health Preparedness of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the biodefense research program of the National Institutes of Health, focusing on the development of medical countermeasures against a bioterrorist attack, February 8, 2005
215   $a1 online resource (iii, 111 p.) $cill
311   $a0-16-074026-6 
517   $aBiodefense 
606   $aBioterrorism$xPrevention$xResearch$zUnited States
606   $aBiological warfare$xHealth aspects$xResearch$zUnited States
606   $aCommunicable diseases$xPrevention$xResearch$zUnited States
610   $aBiological warfare
610   $aCommunicable diseases
610   $aHistory
610   $aMedical
615  0$aBioterrorism$xPrevention$xResearch
615  0$aBiological warfare$xHealth aspects$xResearch
615  0$aCommunicable diseases$xPrevention$xResearch
712 02$aUnited States, Congress Senate Committee on Health, Education, Labor, and Pensions Subcommittee on Bioterrorism and Public Health Preparedness Staff,$4oth
906   $aBOOK
912   $a9910694101103321
996   $aBiodefense$93221059
997   $aUNINA